So
Sonnet Bio
S San Francisco CAFounded 202140 employees
Private CapbiotechPrivateOncology
Platform: Cytokine Eng
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kematinib | SON-7293 | Approved | 4 | KIF18A | Cholangiocarcinoma | ||
| SON-6232 | SON-6232 | Phase 2/3 | 1 | SHP2 | AMLUC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)